KR101968754B1 - 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 - Google Patents

두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 Download PDF

Info

Publication number
KR101968754B1
KR101968754B1 KR1020170033369A KR20170033369A KR101968754B1 KR 101968754 B1 KR101968754 B1 KR 101968754B1 KR 1020170033369 A KR1020170033369 A KR 1020170033369A KR 20170033369 A KR20170033369 A KR 20170033369A KR 101968754 B1 KR101968754 B1 KR 101968754B1
Authority
KR
South Korea
Prior art keywords
dutasteride
weight
probe
hard capsule
moiety
Prior art date
Application number
KR1020170033369A
Other languages
English (en)
Korean (ko)
Other versions
KR20170107933A (ko
Inventor
이병준
김진철
김재호
김용일
박재현
우종수
Original Assignee
한미약품 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한미약품 주식회사 filed Critical 한미약품 주식회사
Publication of KR20170107933A publication Critical patent/KR20170107933A/ko
Application granted granted Critical
Publication of KR101968754B1 publication Critical patent/KR101968754B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020170033369A 2016-03-16 2017-03-16 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 KR101968754B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160031468 2016-03-16
KR20160031468 2016-03-16

Publications (2)

Publication Number Publication Date
KR20170107933A KR20170107933A (ko) 2017-09-26
KR101968754B1 true KR101968754B1 (ko) 2019-04-12

Family

ID=59850978

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170033369A KR101968754B1 (ko) 2016-03-16 2017-03-16 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법

Country Status (8)

Country Link
KR (1) KR101968754B1 (ru)
CN (1) CN109152743B (ru)
AU (1) AU2017233134A1 (ru)
BR (1) BR112018068686A2 (ru)
EA (1) EA201891843A1 (ru)
MX (1) MX2018011208A (ru)
PH (1) PH12018501985A1 (ru)
WO (1) WO2017160106A2 (ru)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
KR101590072B1 (ko) * 2014-12-23 2016-01-29 한미약품 주식회사 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369521B (en) 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
UA80393C2 (ru) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице
EP1618873B1 (de) * 2004-07-14 2007-06-06 Siegfried Generics International AG Granulat zur kontrollierten Freisetzung von Tamsulosin, enthaltend Alginat
CN102247379A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种复方制剂及其制备方法
CN102145007B (zh) * 2011-03-03 2013-03-20 王致中 一种非那雄胺软胶囊与盐酸坦索罗辛胶囊复方制剂、所用胶囊及制备方法
WO2014002015A1 (en) * 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
WO2014147096A1 (en) * 2013-03-19 2014-09-25 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
CN105073100A (zh) * 2013-06-21 2015-11-18 沃克哈特有限公司 坦索罗辛或其盐的药物组合物
ES2555485T1 (es) * 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
KR101590072B1 (ko) * 2014-12-23 2016-01-29 한미약품 주식회사 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물

Also Published As

Publication number Publication date
MX2018011208A (es) 2019-05-30
WO2017160106A3 (ko) 2018-09-07
BR112018068686A2 (pt) 2019-01-15
PH12018501985A1 (en) 2019-07-08
CN109152743B (zh) 2022-01-07
CN109152743A (zh) 2019-01-04
EA201891843A1 (ru) 2019-04-30
KR20170107933A (ko) 2017-09-26
AU2017233134A1 (en) 2018-10-04
WO2017160106A2 (ko) 2017-09-21

Similar Documents

Publication Publication Date Title
JP7394974B2 (ja) 酢酸アビラテロンを含む医薬組成物、並びにその製造方法及び使用
JP3375960B2 (ja) 制御放出オキシコドン組成物
KR102286501B1 (ko) 레날리도마이드의 경구용 정제 조성물
KR20100126465A (ko) 미코페놀레이트를 포함하는 변형 방출 제약 조성물 및 그것의 방법
EP2906202A1 (en) Oral drug delivery formulations
BR112012028035B1 (pt) formulação de liberação imediata
JP2018035171A (ja) 医薬製剤
AU2014299447B2 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
KR20070119700A (ko) 페노피브레이트 및 계면 활성제 혼합물을 함유하는 제제
JP2009527477A (ja) 低紅潮ナイアシン製剤
ES2772137T3 (es) Preparación de composite que comprende una capa de recubrimiento pelicular que contiene principio activo
US20110274753A1 (en) Dual release oral tablet compositions of dexlansoprazole
JP2020500864A (ja) 経口トリデカン酸テストステロン療法
JP2020503269A (ja) 経口ウンデカン酸テストステロン療法
JP2020532517A (ja) 高濃度プリドピジン製剤
KR100798730B1 (ko) 록소프로펜 또는 잘토프로펜 함유 제어방출성 제제 및 그의제조방법
CN109890372B (zh) 含埃索美拉唑的复合胶囊及其制备方法
WO2023241688A1 (zh) 一种用于治疗抗凝血的药物组合物及应用
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
KR101968754B1 (ko) 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법
JP2022514569A (ja) 非晶質スパルセンタン組成物
WO2014002015A1 (en) Pharmaceutical composition comprising dutasteride
KR101499867B1 (ko) 활성 성분 (i) 함유 조성물 및 이의 제조 방법
WO2014003371A1 (ko) 아세브로필린을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물
US10960001B2 (en) Opioid agonist / antagonist combination dosage forms

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant